Re:Biohackers take aim at big pharma’s stranglehold on insulin
by edge17 on Monday June 28, 2021 @04:20PM
(#27667471)
I'm curious, but what does "can't pay" mean? Does it mean the drug cost 100%+ of your income? 10% of your income?
[ Parent
| on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by km3k on Monday June 28, 2021 @04:27PM
(#27667576)
Hard to say, but many drugs can go over 100%. Some could be several hundred percent or more depending on your income. https://www.reuters.com/article/us-vertex-pharms-fda/vertex-...
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by dragonwriter on Monday June 28, 2021 @10:35PM
(#27671074)
It means “the manufacturer realizes they won’t get the price they charge from other channels from you, so is willing to settle for the PR and tax benefits (and whatever residual cost is still charged) rather than nothing.
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by emodendroket on Monday June 28, 2021 @11:29PM
(#27671421)
I mean in many cases the product is still profitable for them at the reduced rate, but why settle?
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by dragonwriter on Tuesday June 29, 2021 @01:00AM
(#27671971)
> I mean in many cases the product is still profitable for them at the reduced rate, but why settle?
Because for a customer who would pay nothing if their only choice was to get the drug at full price, settling for a reduced price (especially when you also get a tax deduction, and some PR benefit from advertising the discount for the needy) is more profitable than not settling.
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by emodendroket on Tuesday June 29, 2021 @08:18AM
(#27674773)
You're not really getting what I'm saying. That's what the program allows them to do, while still charging an exorbitant rate to others.
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by 48309248302 on Monday June 28, 2021 @06:59PM
(#27669407)
Sometimes essential medication costs USD $100,000 per year or more.